Docebo IncDCBO
Price$23.44

Outlook & Key Dates

Estimates, guidance, catalysts, and upcoming events

Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
20.0%projected annual EPS growth
As of 27 Aug 2026
Analyst Coverage
11analysts covering
Consensus: PositiveAs of 18 Aug 2026
FY Revenue (est.)
$274.4Mnext fiscal year
As of 18 Aug 2026
FY EPS (est.)
$1.61next fiscal year
As of 18 Aug 2026
Monitoring Framework
Key Performance Indicators
Annual Recurring Revenue (ARR) Quarterly248.9M
Adjusted EBITDA Margin Quarterly1,680.0%Target: 20.5%
Direct Enterprise Customers with ARR > $100k Annually563
Average Contract Value (ACV) Annually67K
Watch Items
  • Largest OEM Customer ARR ContributionTrigger: ARR contribution from largest OEM customer dropping below 3.0% or experiencing sudden churnAction: Evaluate direct enterprise pipeline growth to offset OEM deceleration and assess impact on overall subscription margins.
  • Free Cash Flow NormalizationTrigger: FCF margin dropping significantly below the historical average or EBITDA marginAction: Monitor working capital timing, collection cycles, and advance payment structures in subsequent quarters.
Sign in / Sign up to read more

Research as of 19 Jun 2026

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.